Accumulating evidence indicates that α‐MG regulates various inflammatory conditions by reducing anti‐collagen II IgG2a antibody production, boosting IL‐10 formation, mitigating ROS‐mediated oxidative stress and posing therapeutic potential in combination with anti‐RA drugs (Herrera‐Aco et al. 2019; Chavan and Muth 2021). The gene discussed is IL10; the disease is rheumatoid arthritis.